You are here:

Accreditation scope for

TEST 099

Oslo universitetssykehus HF

Hormonlaboratoriet og Norges laboratorium for dopinganalyse

Postboks 4959 Nydalen
0424 Oslo

Telephone: Tlf. 22 89 47 08 Faks. 22 15 87 96
E-mail: hormonlaboratoriet@ous-hf.no
Internet: http://www.hormonlaboratoriet.no
The laboratory meets the requirements in

NS-EN ISO/IEC 17025:2017




Accreditation includes:
Hide all Show all
The administrative / geographical unit:
Oslo universitetssykehus HF, Aker, Hormonlaboratoriet
Trondheimsvn. 235
0586 OSLO


Permanent facility
M12 Medical biochemistry
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Urine
Parameter
Chorionic gonadotropin, screening (doping analysis)
Reference standard
Internal method
Internal method identity
ML 67
Comment
ECLIA Cobas e 601
M31 Flexible accreditation
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Body fluids Genetic material
Parameter
Hormone Laboratory’s routine analyses
Reference standard
Internal method
Internal method identity
Measurement principle/analysis platforms accredited under medical biochemistry (M12) Procedure for FA: PS 22 ID log: SS 25
Comment
An updated list of methods included in the flexible scope of accreditation, is available with the organization. Flexibility is limited to analytical principles in the current accreditation scope.
The administrative / geographical unit:
Oslo universitetssykehus HF, Aker, Norges laboratorium for dopinganalyse
Trondheimsvn. 235
0586 OSLO


Permanent facility
M12 Medical biochemistry
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Dried blood spot
Parameter
Anabolic substances, peptide hormones, growth factors, related substances and mimetics, beta-2 agonists, hormone and metabolic modulators, diuretics (diuretics) and masking agents
Reference standard
Internal method
Internal method identity
MD 51
Comment
Extraction from DBS, LC-HRMS. Confirmation
Object
Dried blood spot
Parameter
Anabolic substances: Steroid esters
Reference standard
Internal method
Internal method identity
MD 52
Comment
Extraction from DBS, LC-HRMS. Screening
Object
Dried blood spot
Parameter
Anabolic substances, peptide hormones, growth factors, related substances and mimetics, beta-2 agonists, hormone and metabolic modulators, diuretics (diuretics) and masking agents
Reference standard
Internal method
Internal method identity
MD 50
Comment
Extraction from DBS, LC-HRMS. Screening
Object
Whole blood
Parameter
Haematological parameters
Reference standard
Internal method
Internal method identity
MD 35
Comment
Sysmex instrument: Spectrophotometrifluorescence / flow cytometry, measurement of electrical resistance / hydrodynamic focusing. quantitative determination of blood parameters
Object
Serum
Parameter
Insulin like growth factor 1 (IGF-1)
Reference standard
Internal method
Internal method identity
MD 47
Comment
IRMA, Determination of IGF-1
Object
Serum
Parameter
Endogenous steroids
Reference standard
Internal method
Internal method identity
MD 55
Comment
Protein precipitation with acetonitrile, LC-MS/MS. Quantitative screening.
Object
Serum
Parameter
Recombinant growth hormone
Reference standard
Internal method
Internal method identity
MD 37
Comment
LIA, Determination of recombinant growth hormone
Object
Serum
Parameter
PIIINP
Reference standard
Internal method
Internal method identity
MD 42
Comment
RIA, Determination of PIIINP
Object
Urine
Parameter
Endogenous steriods
Reference standard
Internal method
Internal method identity
MD 34
Comment
Solid phase extraction, hydrolysis, liquid-liquid extraction, GC-MS / MS. Quantification of endogenous steroids
Object
Urine
Parameter
Anabolic substances
Reference standard
Internal method
Internal method identity
MD 18
Comment
Liquid-liquid extraction, GC-MS/MS Analysis of unconjugated doping agents
Object
Urine
Parameter
19-Norandrosterone
Reference standard
Internal method
Internal method identity
MD 22
Comment
Solid phase extraction, hydrolysis and liquid-liquid extraction followed by GC-MS / MS. Confirmation of norandrosterone
Object
Urine
Parameter
Beta blockers
Reference standard
Internal method
Internal method identity
MD 28
Comment
Dilute-and-inject, LC-MS/MS. Screening VII Doping agents
Object
Urine
Parameter
Anabolic substances, peptide hormones, growth factors, related substances and mimetics, hormone and metabolic modulators, diuretics (diuretics) and masking agents, stimulants, narcotics
Reference standard
Internal method
Internal method identity
MD 27
Comment
Dilute-and-inject, LC-MS/MS. Screening V Doping agents
Object
Urine
Parameter
Anabolic substances, hypoxia-inducible factor (HIF) activating agents, diuretics (diuretics), masking agents and stimulants.
Reference standard
Internal method
Internal method identity
MD 53
Comment
Dilute-and-inject, LC-HRMS. Screening
Object
Urine
Parameter
Ephedrines
Reference standard
Internal method
Internal method identity
MD 40
Comment
Dilute-and-inject, LC-MS / MS, Quantification of Ephedrine
Object
Urine
Parameter
Peptides
Reference standard
Internal method
Internal method identity
MD 46
Comment
Solid phase extraction, LC-MS / MS and HRAM LC-MS, Analysis of peptides
Object
Urine
Parameter
Anabolic substances, beta-2 agonists, hormone and metabolic modulators, diuretics (diuretics) and masking agents, stimulants, narcotics, cannabinoids, glucocorticoids, beta blockers
Reference standard
Internal method
Internal method identity
MD 14
Comment
Solid-phase extraction with or without hydrolysis, liquid-liquid extraction, dilute & inject, GC-MS, GC-MS/MS, LC-MS/MS, LC-HRMS. Confirmation of doping agents
Object
Urine
Parameter
Anabole stoffer, beta-2 agonister, hormon- og metabolske modulatorer, diuretika (vanndrivende midler) og maskeringsmidler, stimulerende midler, narkotiske stoffer, cannabinoider, glukokortikoider
Reference standard
Internal method
Internal method identity
MD 10
Comment
Hydrolysis, liquid-liquid extraction followed by GC-MS / MS, LC-MS / MS. Screening of IV Doping agents
Object
Urine
Parameter
Endogenous steroids
Reference standard
Internal method
Internal method identity
MD 36
Comment
Solid phase extraction, hydrolysis, HPLC purification, GC-MS, GC-C-IRMS. Quantification, Isotopratio Mass Spectrometry (IRMS) of endogenous steroids
Object
Urin
Parameter
Specific weight
Reference standard
Internal method
Internal method identity
MD 48
Comment
Refractometer, Specific weight measurement
Object
Urine
Parameter
Formoterol and salbutamol
Reference standard
Internal method
Internal method identity
MD 49
Comment
Solid phase extraction LC-MS / MS, Quantification of formoterol and salbutamol
Object
Urine
Parameter
Cannabis metabolite (THC acid)
Reference standard
Internal method
Internal method identity
MD 32
Comment
Hydrolysis, solid-phase extraction, GC-MS / MS. Quantification of THC acid
Object
Urine
Parameter
Morphine
Reference standard
Internal method
Internal method identity
MD 33
Comment
Hydrolysis, solid-phase extraction, GC-MS. Quantification of morphine
Object
Urine and blood
Parameter
Erythropoietin (EPO) and recombinant analogues (eg NESP, EPO-Fc and CERA)
Reference standard
Internal method
Internal method identity
MD 25
Comment
Immunoaffinity purification, gelelektroforese, western blott, Chemiiluminescens. Determination of EPO and recombinant analogues
M31 Flexible accreditation
Object
Parameter
Reference standard
Internal method identity
Comment
Object
Body fluids Dried blood spot
Parameter
Doping analysis
Reference standard
Internal method
Internal method identity
Measurement principle / analysis platforms that are accredited under medical biochemistry (M12) Procedure for FA: PD 41 ID log: SD 51
Comment
An updated list of methods included in the flexible scope of accreditation, is available with the organization. Flexibility is limited to analytical principles in the current accreditation scope.